共 13 条
- [1] Antitumor activity of PLX4032, a novel B-Raf V600E inhibitorEJC SUPPLEMENTS, 2006, 4 (12): : 172 - 173Lee, J. T.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USAKong, J.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USASmalley, K.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USATsai, J.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USACho, H.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USABollag, G.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USAHerlyn, M.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Mol & Cellular Oncogen, Philadelphia, PA 19104 USA
- [2] The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (33) : 14903 - 14908Joseph, Eric W.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Weill Cornell Grad Sch Med Sci, Program Biochem Cell & Mol Biol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAPratilas, Christine A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAPoulikakos, Poulikos I.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USATadi, Madhavi论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAWang, Weiqing论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USATaylor, Barry S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAHalilovic, Ensar论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Weill Cornell Grad Sch Med Sci, Program Pharmacol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAPersaud, Yogindra论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Human Oncol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAXing, Feng论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Human Oncol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAViale, Agnes论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USATsai, James论文数: 0 引用数: 0 h-index: 0机构: Plexxikon Inc, Berkeley, CA 94710 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USAChapman, Paul B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USABollag, Gideon论文数: 0 引用数: 0 h-index: 0机构: Plexxikon Inc, Berkeley, CA 94710 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USASolit, David B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Human Oncol, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USARosen, Neal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA
- [3] A case series of BRAF V600E inhibitor (PLX4032) related cutaneous eruptions in metastatic melanomaBRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 19 - 19Sinha, R.论文数: 0 引用数: 0 h-index: 0机构: Chelsea & Westminster Hosp NHS Fdn Trust, London, England Chelsea & Westminster Hosp NHS Fdn Trust, London, EnglandFearfield, L.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, London, England Chelsea & Westminster Hosp NHS Fdn Trust, London, EnglandLarkin, J.论文数: 0 引用数: 0 h-index: 0机构: Chelsea & Westminster Hosp NHS Fdn Trust, London, England Chelsea & Westminster Hosp NHS Fdn Trust, London, England
- [4] Multiple murine BRaf V600E melanoma cell lines with sensitivity to PLX4032PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (03) : 495 - 501Jenkins, Molly H.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Norris Cotton Canc Ctr, Lebanon, NH USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USASteinberg, Shannon M.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Norris Cotton Canc Ctr, Lebanon, NH USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USAAlexander, Matthew P.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Norris Cotton Canc Ctr, Lebanon, NH USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USAFisher, Jan L.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USAErnstoff, Marc S.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USATurk, Mary Jo论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Norris Cotton Canc Ctr, Lebanon, NH USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USAMullins, David W.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Norris Cotton Canc Ctr, Lebanon, NH USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USABrinckerhoff, Constance E.论文数: 0 引用数: 0 h-index: 0机构: Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA Geisel Sch Med Dartmouth, Dept Biochem, Norris Cotton Canc Ctr, Lebanon, NH USA Geisel Sch Med Dartmouth, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA
- [5] PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasPIGMENT CELL & MELANOMA RESEARCH, 2010, 23 (06) : 820 - 827Lee, John T.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USALi, Ling论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USABrafford, Patricia A.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USAvan den Eijnden, Marcia论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USAHalloran, Molly B.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USASproesser, Katrin论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USAHaass, Nikolas K.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USASmalley, Keiran S. M.论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USATsai, James论文数: 0 引用数: 0 h-index: 0机构: Plexxikon Inc, Berkeley, CA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USABollag, Gideon论文数: 0 引用数: 0 h-index: 0机构: Plexxikon Inc, Berkeley, CA USA Wistar Inst Anat & Biol, Dept Mol & Cellular Oncogenesis, Philadelphia, PA USA论文数: 引用数: h-index:机构:
- [6] Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancerJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Flaherty, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USAPuzanov, I.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USASosman, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USAKim, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USARibas, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USAMcArthur, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USALee, R. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USAGrippo, J. F.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USANolop, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USAChapman, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA
- [7] Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant MelanomaANTICANCER RESEARCH, 2022, 42 (06) : 2911 - 2921Poudel, Muna论文数: 0 引用数: 0 h-index: 0机构: Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South KoreaKim, Garam论文数: 0 引用数: 0 h-index: 0机构: Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South KoreaBhattarai, Poshan Yugal论文数: 0 引用数: 0 h-index: 0机构: Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South KoreaShin, Seung论文数: 0 引用数: 0 h-index: 0机构: Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South KoreaZaraei, Seyed-Omar论文数: 0 引用数: 0 h-index: 0机构: Korea Inst Sci & Technol, Ctr Biomat, Seoul, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South KoreaOh, Chang-Hyun论文数: 0 引用数: 0 h-index: 0机构: Korea Inst Sci & Technol, Ctr Biomat, Seoul, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South KoreaChoi, Hong Seok论文数: 0 引用数: 0 h-index: 0机构: Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South Korea Chosun Univ, Coll Pharm, 309 Pilmun Daero, Gwangju 501759, South Korea
- [8] Constitutively active RAS and MEK confer resistance to PLX4032 in BRAF-V600E human melanoma cellsCANCER RESEARCH, 2011, 71Somers-Edgar, Tiffany J.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaFerrao, Petranel论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaCallahan, Jason论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaBollag, Gideon论文数: 0 引用数: 0 h-index: 0机构: Plexxikon Inc, Berkeley, CA USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaHicks, Rod论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaJohnstone, Ricky论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaMcArthur, Grant A.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
- [9] RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)NATURE, 2011, 480 (7377) : 387 - U144Poulikakos, Poulikos I.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAPersaud, Yogindra论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAJanakiraman, Manickam论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAKong, Xiangju论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USANg, Charles论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAMoriceau, Gatien论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAShi, Hubing论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAAtefi, Mohammad论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USATitz, Bjoern论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAGabay, May Tal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USASalton, Maayan论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USADahlman, Kimberly B.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USATadi, Madhavi论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAWargo, Jennifer A.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Boston, MA 02114 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAFlaherty, Keith T.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAKelley, Mark C.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Dept Surg, Nashville, TN 37232 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAMisteli, Tom论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAChapman, Paul B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USASosman, Jeffrey A.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USAGraeber, Thomas G.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USARibas, Antoni论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USALo, Roger S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USARosen, Neal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USASolit, David B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
- [10] RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)Nature, 2011, 480 : 387 - 390Poulikos I. Poulikakos论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryYogindra Persaud论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryManickam Janakiraman论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryXiangju Kong论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryCharles Ng论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryGatien Moriceau论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryHubing Shi论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryMohammad Atefi论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryBjoern Titz论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryMay Tal Gabay论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryMaayan Salton论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryKimberly B. Dahlman论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryMadhavi Tadi论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryJennifer A. Wargo论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryKeith T. Flaherty论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryMark C. Kelley论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryTom Misteli论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryPaul B. Chapman论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryJeffrey A. Sosman论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryThomas G. Graeber论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryAntoni Ribas论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryRoger S. Lo论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryNeal Rosen论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and ChemistryDavid B. Solit论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan-Kettering Cancer Center,Department of Molecular Pharmacology and Chemistry